»
Antikörper
»
anti-Human Class II beta-Tubulin Antikörper
Human Class II beta-Tubulin Antikörper
| Antigen |
|
| Synonyme |
MC1R, TUBB4, beta-4, TUBB3, MGC134115, tbb3 |
| Klonalität |
Monoklonal (Cov7B9) |
|
Wirt
|
|
|
Reaktivität
|
|
|
Applikation
|
Alternativen Immunzytochemie (ICC), Immunpräzipitation (IP), Western Blot (WB)
|
| Produktnummer |
ABIN346894 |
| Menge |
100 µl (Varianten) |
| Preis |
210,00 € Zzgl. Versandkosten €20,00 und MWSt
|
| Lieferung nach |
|
| Verfügbarkeit |
Lieferung in 3 bis 5 Werktagen |
|
Immunogen
|
CII beta-Tubulin protein
|
|
Format
|
Ascites
|
|
Isotyp
|
IgG1 kappa (Passende Sekundärantikörper)
|
|
Klon
|
Cov7B9
|
|
Spezifität
|
Monoclonal antibody reacts specifically with human class II beta-Tubulin (10 kDa). Cross Reactivities: Not yet tested
|
|
Applikationshinweise
|
Optimal dilutions should be determined by the end user. The following are guidelines only: Immunocytochemistry : 1/200 to 1/1 000. Immunoprecipitation : 1/50 to 1/200. Western Blot : 1/200 to 1/1 000
|
|
Buffer
|
Lyophilized from 100 µl of ascitic fluid. Preservative: None.
|
|
Lagerung
|
Short term storage: +4°C. Long term storage: -20°C
|
|
Beschränkungen
|
Nur für Forschungszwecke einsetzbar
|
|
Publikationen
|
Sueve, Reiman, Lai et al.: "Class III beta-tubulin is a marker of paclitaxel resistance in carcinomas of unknown primary site." in: Cancer chemotherapy and pharmacology, Vol. 60, Issue 1, pp. 27-34, 2007 (PubMed).
Sueve, Lai, Ding et al.: "Class III beta-tubulin expression and benefit from adjuvant cisplatin/vinorelbine chemotherapy in operable non-small cell lung cancer: analysis of NCIC JBR.10." in: Clinical cancer research : an official journal of the American Association for Cancer Research, Vol. 13, Issue 3, pp. 994-9, 2007 (PubMed).
|
Alternativen zu Antigen "Human Class II beta-Tubulin", Typ "Antikörper" finden